Technology
Health
Biotechnology

Oragenics

$0.4815
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0056 (1.21%) Today
+$0.0123 (2.62%) As of 5:41 PM EDT after-hours

Why Robinhood?

You can buy or sell Oragenics and other stocks, options, ETFs, and crypto commission-free!

About OGEN

Oragenics Inc., also called Oragenics, is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. Read More The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Employees
6
Headquarters
Tampa, Florida
Founded
1996
Market Cap
21.38M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
515.01K
High Today
$0.4717
Low Today
$0.4506
Open Price
$0.4656
Volume
942.14K
52 Week High
$3.74
52 Week Low
$0.38

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
US
North America

OGEN Earnings

Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 13, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.